Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment improved COVID-19 outcomes, and spironolactone helped reduce risks in females with high androgen levels.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

COVID-19 can cause hair loss, and treatments like PRP and stem cells might help.

During the COVID-19 pandemic, more people were diagnosed with stress-related skin conditions like acne and temporary hair loss.

Different methods, including stress management, healthy diet, supplements, and treatments like minoxidil, can help hair grow back after COVID-19 related hair loss.

Long COVID is a serious, long-lasting illness that needs more recognition and support.

Shi-Bi-Man helps hair regrowth by activating the FGF pathway in cells.

No significant link between male pattern baldness and COVID-19 severity was found.

COVID-19 can cause rashes and worsen existing skin conditions, and behaviors like frequent hand-washing can lead to hand dermatitis.

COVID-19 vaccines have been linked to an increase in hair loss conditions.

Some COVID-19 patients have skin issues, with men, ICU patients, and those on multiple antibiotics at higher death risk; in-person skin checks by dermatologists are more effective.

Certain skin symptoms in COVID-19 patients may indicate a more severe illness.

COVID-19 can cause various skin symptoms, including rashes and lesions, which often appear early and can help in timely diagnosis.

Long COVID causes lasting symptoms and needs ongoing care.

Polymeric nanoparticles could improve hair loss treatments by delivering drugs more effectively to hair follicles.

Low-dose oral minoxidil helps hair regrowth in COVID-19-related hair loss with few side effects.

More people experience hair loss after recovering from COVID-19 in hospitals than in outpatient settings.

Post-COVID-19 patients are at risk for hair loss.

COVID-19 may cause a common type of hair loss called telogen effluvium.

COVID-19 can cause temporary hair loss in some patients, affecting their quality of life.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Protein analysis shows aging changes in scalp cell types from women.

Post-COVID-19 patients often experience musculoskeletal issues, fitness decline, behavioral changes, chest pain, cough, hair loss, and nervous system problems.

Hair loss is not clearly linked to COVID-19 vaccination in Egyptians.

COVID-19 can cause hair loss, often treated effectively with a combination of supplements and topical treatments.

COVID-19 may cause hair loss due to the virus's effects and stress from the pandemic.

Skin aging and cancer development are influenced by the competition between stem cells.

Low oxygen levels affect the behavior of certain proteins in human skin cells.

Human-induced stem cell-created skin models can help understand skin diseases by studying the skin's layers.